Minerva Neurosciences Inc logo

Minerva Neurosciences Inc

NAS:NERV (USA)  
$ 2.12 0 (0%) 11:08 PM EST
At Loss
Market Cap:
$ 14.83M
Enterprise V:
$ -11.42M
Volume:
5.44K
Avg Vol (2M):
30.20K
Trade In:
Volume:
5.44K
At Loss
Avg Vol (2M):
30.20K

Business Description

Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -0.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 7.2
3-Year FCF Growth Rate 29.9
Name Current Vs Industry Vs History
5-Day RSI 34.13
9-Day RSI 39.89
14-Day RSI 41.77
6-1 Month Momentum % -31.08
12-1 Month Momentum % -67.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.23
Quick Ratio 6.23
Cash Ratio 5.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.4

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -3.32
EV-to-EBITDA -3.29
EV-to-FCF 0.57
Earnings Yield (Greenblatt) % -30.12
FCF Yield % -137.41

Financials (Next Earnings Date:2025-02-21 Est.)

NERV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NERV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Minerva Neurosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.45
Beta -0.24
Volatility % 88.81
14-Day RSI 41.77
14-Day ATR ($) 0.127484
20-Day SMA ($) 2.208745
12-1 Month Momentum % -67.25
52-Week Range ($) 2.06 - 13.49
Shares Outstanding (Mil) 6.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Minerva Neurosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Minerva Neurosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Minerva Neurosciences Inc Frequently Asked Questions

What is Minerva Neurosciences Inc(NERV)'s stock price today?
The current price of NERV is $2.12. The 52 week high of NERV is $13.49 and 52 week low is $2.06.
When is next earnings date of Minerva Neurosciences Inc(NERV)?
The next earnings date of Minerva Neurosciences Inc(NERV) is 2025-02-21 Est..
Does Minerva Neurosciences Inc(NERV) pay dividends? If so, how much?
Minerva Neurosciences Inc(NERV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1